- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Fuji Pharma's net sales composition FY 2018, by therapeutic category
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Fuji Pharma's net sales composition FY 2018, by therapeutic category
Net sales of Fuji Pharma Co. Ltd. in fiscal year 2018, by therapeutic category (in billion Japanese yen)
by Statista Research Department,
last edited
May 8, 2019
This statistic illustrates the net sales of the Japanese pharmaceutical company Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018, sorted by therapeutic category. In fiscal year 2018, diagnostic drugs made up the largest portion of Fuji Pharma's sales with net sales amounting to around 11.2 billion Japanese yen.
Net sales of Fuji Pharma Co. Ltd. in fiscal year 2018, by therapeutic category (in billion Japanese yen)
| Net sales in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Net sales in billion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
May 8, 2019
This statistic illustrates the net sales of the Japanese pharmaceutical company Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018, sorted by therapeutic category. In fiscal year 2018, diagnostic drugs made up the largest portion of Fuji Pharma's sales with net sales amounting to around 11.2 billion Japanese yen.
- Show sources information
- Show publisher information
- Release date
- November 2018
- Region
- Japan
- Survey time period
- fiscal year 2018; fiscal year ended September 30
- Special properties
- consolidated data
- Supplementary notes
-
1 Japanese yen equals 0.009 U.S. dollars or 0.0081 euros as of May 2019.
Figures have been rounded.
Source
- Show sources information
- Show publisher information
- Release date
- November 2018
More information
- Region
- Japan
- Survey time period
- fiscal year 2018; fiscal year ended September 30
- Special properties
- consolidated data
- Supplementary notes
-
1 Japanese yen equals 0.009 U.S. dollars or 0.0081 euros as of May 2019.
Figures have been rounded.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Fuji Pharma's sales composition FY 2018, by therapeutic category
- Fuji Pharma's total assets FY 2013-2018
- Fuji Pharma's net sales FY 2013-2018
- Fuji Pharma's R&D costs FY 2013-2018
- Fuji Pharma's net income FY 2013-2018
- Fuji Pharma's operating profit FY 2013-2018
- Rebates/discounts by select companies as share of US pharma sales 2009-2013
- Top pharmaceutical companies in Colombia 2016, by sales
- Most advertised prescription drugs in the U.S. in 2017, by print ad spending
- Prescription drug advertising in the U.S. 2010-2014
- Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
- Number of companies in the pharmaceutical industry in France 1970-2016
- Pharmaceutical corporations by U.S. market share 2016
- Pharmaceutical corporations by U.S. sales 2010
- Market cap of select pharma companies with strong pipeline 2017
- JW Pharmaceutical's R&D spending ratio South Korea 2014-2018
- Brazil: net profit of Bayer 2015-2016
- JW Pharmaceutical's operating profit 2014-2018
- JW Pharmaceutical's sales revenue distribution South Korea 2018, by channel
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
Studies
- Pharmaceutical trends in Europe
- Pharmaceutical industry in India
- Dechra Pharmaceuticals PLC Annual Report 2018
- Pharmaceutical industry in Italy
- Indicatori Farmaceutici
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Vaccine industry in China
- Boehringer Ingelheim - Annual Report 2018
- Pharmaceutical industry in the Netherlands
- 2019 PhRMA Annual Membership Survey
- Medtronic - 2019 Form 10-K
- California Life Sciences Industry Report 2019
- Generic Pharmaceutical Industry Yearbook 2016
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Sales distribution of Fuji Pharma Co. Ltd. in fiscal year 2018, by therapeutic category
- Total assets of Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)
- Net sales of Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)
- Research and development (R&D) expenses of Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)
- Profit of Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)*
- Operating profit of Fuji Pharma Co. Ltd. from fiscal year 2013 to 2018 (in billion Japanese yen)
- Rebates and discounts by selected companies as share of their U.S. pharmaceutical sales from 2009 to 2013
- Leading pharmaceutical companies in Colombia in 2016, by sales (in billion Colombian pesos)
- Most advertised prescription drugs in the United States in 2017, by print advertising spending (in million U.S. dollars)
- Prescription drug advertising in the United States from 2010 to 2014 (in billion U.S. dollars)
- Global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012 (in billion U.S. dollars)
- Number of companies in the pharmaceutical drug industry in France from 1970 to 2016*
- Top 10 pharmaceutical corporations by U.S. market share in 2016 (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. sales in 2010 (in billion U.S. dollars)
- Market capitalization of select therapeutic pharmaceutical companies as of 2017 (in billion U.S. dollars)*
- JW Pharmaceutical's research and development (R&D) expenditure to sales ratio from 2014 to 2018 (in billion South Korean won)
- Net profit of Bayer in Brazil in 2015 and 2016 (in million U.S. dollars)
- Operating profit of JW Pharmaceutical around the world from 2014 to 2018 (in billion South Korean won)
- Sales revenue distribution of JW Pharmaceutical in South Korea as of December 2018, by channel
- Enterprise value of leading pure players in non-oncology rare disease therapeutics worldwide as of 2017 (in million U.S. dollars)*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.